drugset / Trial / NCT06380660
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if the experimental treatment with poly-ADP ribose polymerase (PARP) inhibitor, ACE-86225106 is safe, tolerable and has anti-cancer activity in adult patients with advanced solid tumors.
Timeline
- Start
- 2024-03-22
- Primary completion
- 2028-12-21
- Completion
- 2029-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACE-86225106 | Unknown | — | Oral |